Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow

Are you up to date on the evolving treatment landscape for HER2-mutated non-small cell lung cancer (NSCLC)? Do you know the role of novel targeted therapies?

Credit available for this activity expires: 12/24/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-oncology-her2-mutated-nsclc-strategies-today-and-2025a100105r?ecd=bdc_podcast_libsyn_mscpedu